Biomaterial Database

The dopaminergic actions of B-HT 920. 1990

S K Kulkarni, and K Chopra

Department of Pharmaceutical Sciences, Panjab University, Chandigarh, India.

B-HT 920 (2-amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo-[4,5-d]-azepine), an alpha 2-adrenoceptor agonist has been reported to modulate dopamine (DA) receptor activity. Earlier studies speculated the DA autoreceptor action of B-HT 920. However, some recent studies have indicated that the stimulatory effects of B-HT 920 are sensitive to blockade by sulpiride and haloperidol, suggesting a postsynaptic D2-dopamine receptor action. The article briefly reviews the current concepts about DAergic actions of B-HT 920.

UI	MeSH Term	Description	Entries
D011954	Receptors, Dopamine	Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells.	Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818	Animals	Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA.	Animal,Metazoa,Animalia
D001381	Azepines	Seven membered heterocyclic rings containing a NITROGEN atom.	Hexamethyleneimines
D015259	Dopamine Agents	Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.	Dopamine Drugs,Dopamine Effect,Dopamine Effects,Dopaminergic Agents,Dopaminergic Drugs,Dopaminergic Effect,Dopaminergic Effects,Agents, Dopamine,Agents, Dopaminergic,Drugs, Dopamine,Drugs, Dopaminergic,Effect, Dopamine,Effect, Dopaminergic,Effects, Dopamine,Effects, Dopaminergic